Entrepreneurial, Innovative, Customer Centric, R&D leader for disruptive platforms in lifesciences.Experienced in scientific strategy, competitive intelligence, portfolio management and content development. IVD 510k, Quality and QC processes, Organic and Analytical Chemistry expertiseReviewer in several NIH SBIR/STTR study sections, infectious disease and point of care device development Sr Director Reagents and Biology at Caliper Lifesciences through acquisition by Perkin Elmer headed R&D creating and implementing cost effective, easy to implement reagent and assay content to all of PKI technology platforms using microfluidics, automation, preclinical imaging and next gen sequencing sample preparation addressing the life sciences, medical diagnostics, agbio and environmental market segments. Head of Chemistry at DiscoveRx, launched numerous products from concept to commercialization targeting the HTS and HCS drug discovery market segments with optical readouts. Creation, acquisition, licensing and monetization of IP. Led Metabolomics and Proteomics at Surromed to devise infrastructure for mass spectrometric, laser scanning cytometry, immunoassay and clinical diagnostics based screening of biological samples for biomarker discovery targeted towards patient stratification. Developed assay technologies for companion medical diagnostics in IVD and life science RUO instrumentation. Team behind LOCI/ALPHA which has had 3+ billion datapoints screened, culminating with melanoma drug Zelboraf NDA (Roche) and launched by Siemens for clinical diagnostics. Co-authored a number of publications and co-invented over 25 patents almost all of which have resulted in revenue generating products. PhD under Prof. Ronald Breslow (Columbia University) where precursors to anticancer drug Vorinostat (Zolinza, Merck ) were synthesized and seminal epigenetic assays developed at Memorial Sloan Kettering Hospital. Specialties: Assay Guru, Competitive analysis, Intellectual property, design of experiments, organic. physical and analytical chemistry, drug discovery, innovation, outsourcing, customer and CRO liaison, newborn screening, rare diseases, IVD FDA clearances, microfluidics and point of care devices